Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Autoimmune Diseases D001327 27 associated lipids
Endotoxemia D019446 27 associated lipids
Neuralgia D009437 28 associated lipids
Insulinoma D007340 28 associated lipids
Proteinuria D011507 30 associated lipids
Acute Lung Injury D055371 33 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Acne Vulgaris D000152 35 associated lipids
Anaphylaxis D000707 35 associated lipids
Heart Failure D006333 36 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Adenoma D000236 40 associated lipids
Arthritis D001168 41 associated lipids
Hyperalgesia D006930 42 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Liver Neoplasms, Experimental D008114 46 associated lipids
Psoriasis D011565 47 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Asthma D001249 52 associated lipids
Nerve Degeneration D009410 53 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Pain D010146 64 associated lipids
Reperfusion Injury D015427 65 associated lipids
Neuroblastoma D009447 66 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Colitis D003092 69 associated lipids
Melanoma D008545 69 associated lipids
Coronary Disease D003327 70 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Leukemia D007938 74 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Atherosclerosis D050197 85 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Arteriosclerosis D001161 86 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Insulin Resistance D007333 99 associated lipids
Weight Gain D015430 101 associated lipids
Glioma D005910 112 associated lipids
Hypertension D006973 115 associated lipids
Inflammation D007249 119 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Hemolysis D006461 131 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Edema D004487 152 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Adenocarcinoma D000230 166 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Su SC et al. Annexin 2 regulates endothelial morphogenesis by controlling AKT activation and junctional integrity. 2010 J. Biol. Chem. pmid:20947498
Chen JH et al. Sphingosine kinase regulates oxidized low density lipoprotein-mediated calcium oscillations and macrophage survival. 2010 J. Lipid Res. pmid:19965613
Shea BS et al. Prolonged exposure to sphingosine 1-phosphate receptor-1 agonists exacerbates vascular leak, fibrosis, and mortality after lung injury. 2010 Am. J. Respir. Cell Mol. Biol. pmid:20081052
He X et al. Deregulation of sphingolipid metabolism in Alzheimer's disease. 2010 Neurobiol. Aging pmid:18547682
Nam JH et al. Ca2+ signaling induced by sphingosine 1-phosphate and lysophosphatidic acid in mouse B cells. 2010 Mol. Cells pmid:20069383
Gil PR et al. Sphingosine 1-phosphate mediates chemotaxis of human primary fibroblasts via the S1P-receptor subtypes S1P₁ and S1P₃ and Smad-signalling. 2010 Cytoskeleton (Hoboken) pmid:20857421
Dudek SM et al. Abl tyrosine kinase phosphorylates nonmuscle Myosin light chain kinase to regulate endothelial barrier function. 2010 Mol. Biol. Cell pmid:20861316
Yamamoto Y et al. Increased expression of enzymes for sphingosine 1-phosphate turnover and signaling in human decidua during late pregnancy. 2010 Biol. Reprod. pmid:20007411
Wang S et al. A polysaccharide, MDG-1, induces S1P1 and bFGF expression and augments survival and angiogenesis in the ischemic heart. 2010 Glycobiology pmid:20008963
Herzog C et al. Intravenous sphingosylphosphorylcholine protects ischemic and postischemic myocardial tissue in a mouse model of myocardial ischemia/reperfusion injury. 2010 Mediators Inflamm. pmid:21274265
He X et al. Sphingosine-1-phosphate mediates proliferation maintaining the multipotency of human adult bone marrow and adipose tissue-derived stem cells. 2010 J Mol Cell Biol pmid:20584786
Thangada S et al. Cell-surface residence of sphingosine 1-phosphate receptor 1 on lymphocytes determines lymphocyte egress kinetics. 2010 J. Exp. Med. pmid:20584883
Baker DA et al. Genetic sphingosine kinase 1 deficiency significantly decreases synovial inflammation and joint erosions in murine TNF-alpha-induced arthritis. 2010 J. Immunol. pmid:20644167
Lan T et al. Berberine ameliorates renal injury in diabetic C57BL/6 mice: Involvement of suppression of SphK-S1P signaling pathway. 2010 Arch. Biochem. Biophys. pmid:20646989
Incorvaia C et al. Anaphylaxis: an update on its understanding and management. 2010 Recent Pat Inflamm Allergy Drug Discov pmid:20100165
Zhou Y et al. Isoflurane posttreatment reduces neonatal hypoxic-ischemic brain injury in rats by the sphingosine-1-phosphate/phosphatidylinositol-3-kinase/Akt pathway. 2010 Stroke pmid:20508187
Pchejetski D et al. Circulating sphingosine-1-phosphate inversely correlates with chemotherapy-induced weight gain during early breast cancer. 2010 Breast Cancer Res. Treat. pmid:20535545
Leong WI and Saba JD S1P metabolism in cancer and other pathological conditions. 2010 Biochimie pmid:20167244
Ma B et al. Stereochemistry-activity relationship of orally active tetralin S1P agonist prodrugs. 2010 Bioorg. Med. Chem. Lett. pmid:20188554
Serebrov VIu et al. [Activity of the sphingomyelin cycle enzymes and concentration of products of sphingomyelin degradation in the rat liver in the course of acute toxic hepatitis]. 2010 Mar-Apr Biomed Khim pmid:21341516
Knapp M Cardioprotective role of sphingosine-1-phosphate. 2011 J. Physiol. Pharmacol. pmid:22314562
Berdyshev EV et al. Intracellular S1P generation is essential for S1P-induced motility of human lung endothelial cells: role of sphingosine kinase 1 and S1P lyase. 2011 PLoS ONE pmid:21304987
Schuchardt M et al. Pharmacological relevance and potential of sphingosine 1-phosphate in the vascular system. 2011 Br. J. Pharmacol. pmid:21309759
Kikuta J et al. [Encounter of cancer cells with bone. In vivo imaging of osteoclasts and their precursors in intact bone tissues]. 2011 Clin Calcium pmid:21358058
Mair N et al. Genetic evidence for involvement of neuronally expressed S1P₁ receptor in nociceptor sensitization and inflammatory pain. 2011 PLoS ONE pmid:21359147
Morris MA et al. Prevention, but not cure, of autoimmune diabetes in a NOD.scid transfer model by FTY720 despite effective modulation of blood T cells. 2011 Autoimmunity pmid:20695767
Ishii T et al. The role of sphingosine 1-phosphate in migration of osteoclast precursors; an application of intravital two-photon microscopy. 2011 Mol. Cells pmid:21360199
Antel J and Hohlfeld R Modulation of sphingosine 1-phosphate signaling in neurologic disease. 2011 Neurology pmid:21360856
Hagen N et al. Sphingosine-1-phosphate links glycosphingolipid metabolism to neurodegeneration via a calpain-mediated mechanism. 2011 Cell Death Differ. pmid:21331079
Lépine S et al. Sphingosine-1-phosphate phosphohydrolase-1 regulates ER stress-induced autophagy. 2011 Cell Death Differ. pmid:20798685
Kim MG et al. CD4+ CD25+ regulatory T cells partially mediate the beneficial effects of FTY720, a sphingosine-1-phosphate analogue, during ischaemia/reperfusion-induced acute kidney injury. 2011 Nephrol. Dial. Transplant. pmid:20702533
Jiang Z et al. Metabonomic study on women of reproductive age treated with nutritional intervention: screening potential biomarkers related to neural tube defects occurrence. 2011 Biomed. Chromatogr. pmid:20812204
Durafourt BA et al. Differential responses of human microglia and blood-derived myeloid cells to FTY720. 2011 J. Neuroimmunol. pmid:20826007
Adyshev DM et al. Differential involvement of ezrin/radixin/moesin proteins in sphingosine 1-phosphate-induced human pulmonary endothelial cell barrier enhancement. 2011 Cell. Signal. pmid:21864676
Selim S et al. Plasma levels of sphingosine 1-phosphate are strongly correlated with haematocrit, but variably restored by red blood cell transfusions. 2011 Clin. Sci. pmid:21749329
Kim DS et al. Sphingosine-1-phosphate decreases melanin synthesis via microphthalmia-associated transcription factor phosphorylation through the S1P3 receptor subtype. 2011 J. Pharm. Pharmacol. pmid:21749389
Kojima K and Inouye K Activation of matriptase zymogen. 2011 J. Biochem. pmid:21737400
AL-Shawaf E et al. GVI phospholipase A2 role in the stimulatory effect of sphingosine-1-phosphate on TRPC5 cationic channels. 2011 Cell Calcium pmid:21742378
Bautista-Pérez R et al. Sphingosine-1-phosphate induced vasoconstriction is increased in the isolated perfused kidneys of diabetic rats. 2011 Diabetes Res. Clin. Pract. pmid:21775010
Roviezzo F et al. Sphingosine-1-phosphate modulates vascular permeability and cell recruitment in acute inflammation in vivo. 2011 J. Pharmacol. Exp. Ther. pmid:21421740
Murakami M et al. Sphingosine kinase 1/S1P pathway involvement in the GDNF-induced GAP43 transcription. 2011 J. Cell. Biochem. pmid:21769916
Yu Y and Qin SC [An active lipid signaling molecule: sphingosine-1-phosphate and its biological characteristics]. 2011 Sheng Li Ke Xue Jin Zhan pmid:21770269
Tanfin Z et al. ATP-binding cassette ABCC1 is involved in the release of sphingosine 1-phosphate from rat uterine leiomyoma ELT3 cells and late pregnant rat myometrium. 2011 Cell. Signal. pmid:21803151
Gault CR and Obeid LM Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy. 2011 Crit. Rev. Biochem. Mol. Biol. pmid:21787121
Qadri SM et al. Sphingosine but not sphingosine-1-phosphate stimulates suicidal erythrocyte death. 2011 Cell. Physiol. Biochem. pmid:21865742
Lee YS et al. Serine palmitoyltransferase inhibitor myriocin induces growth inhibition of B16F10 melanoma cells through G(2) /M phase arrest. 2011 Cell Prolif. pmid:21645154
Zhao Z et al. Sphingosine-1-phosphate promotes the differentiation of human umbilical cord mesenchymal stem cells into cardiomyocytes under the designated culturing conditions. 2011 J. Biomed. Sci. pmid:21645412
Kim ES et al. Sphingosine 1-phosphate regulates matrix metalloproteinase-9 expression and breast cell invasion through S1P3-Gαq coupling. 2011 J. Cell. Sci. pmid:21652634
Lim KG et al. (R)-FTY720 methyl ether is a specific sphingosine kinase 2 inhibitor: Effect on sphingosine kinase 2 expression in HEK 293 cells and actin rearrangement and survival of MCF-7 breast cancer cells. 2011 Cell. Signal. pmid:21620961
Egom EE et al. Activation of Pak1/Akt/eNOS signaling following sphingosine-1-phosphate release as part of a mechanism protecting cardiomyocytes against ischemic cell injury. 2011 Am. J. Physiol. Heart Circ. Physiol. pmid:21705677
Yangyuoru PM et al. Determination of sphingosine kinase 2 activity using fluorescent sphingosine by capillary electrophoresis. 2011 Electrophoresis pmid:21706498
Kawahara A [Genetic dissection of cardiac morphogenesis in zebrafish]. 2011 Seikagaku pmid:21706872
Burns TA and Luberto C Sphingolipid metabolism and leukemia: a potential for novel therapeutic approaches. 2011 Anticancer Agents Med Chem pmid:21707485
Cuvillier O and Ader I Hypoxia-inducible factors and sphingosine 1-phosphate signaling. 2011 Anticancer Agents Med Chem pmid:21707486
Bedia C et al. Regulation of autophagy by sphingolipids. 2011 Anticancer Agents Med Chem pmid:21707487
Weigert A et al. S1P regulation of macrophage functions in the context of cancer. 2011 Anticancer Agents Med Chem pmid:21707489
Watters RJ et al. Targeting sphingosine-1-phosphate receptors in cancer. 2011 Anticancer Agents Med Chem pmid:21707490
Stevenson CE et al. Targeting sphingosine-1-phosphate in hematologic malignancies. 2011 Anticancer Agents Med Chem pmid:21707492
Bourquin F et al. PLP-dependent enzymes as entry and exit gates of sphingolipid metabolism. 2011 Protein Sci. pmid:21710479
Sánchez BA et al. Targeted analysis of sphingoid precursors in human biofluids by solid-phase extraction with in situ derivatization prior to μ-LC-LIF determination. 2011 Anal Bioanal Chem pmid:21394454
Dickson MA et al. A phase I clinical trial of safingol in combination with cisplatin in advanced solid tumors. 2011 Clin. Cancer Res. pmid:21257722
Kumar A et al. S1P lyase regulates DNA damage responses through a novel sphingolipid feedback mechanism. 2011 Cell Death Dis pmid:21368890
Schröder M et al. The sphingosine kinase 1 and S1P1 axis specifically counteracts LPS-induced IL-12p70 production in immune cells of the spleen. 2011 Mol. Immunol. pmid:21435724
Kujjo LL et al. Chemotherapy-induced late transgenerational effects in mice. 2011 PLoS ONE pmid:21437292
Bandhuvula P et al. S1P lyase: a novel therapeutic target for ischemia-reperfusion injury of the heart. 2011 Am. J. Physiol. Heart Circ. Physiol. pmid:21335477
Kennedy AJ et al. Development of amidine-based sphingosine kinase 1 nanomolar inhibitors and reduction of sphingosine 1-phosphate in human leukemia cells. 2011 J. Med. Chem. pmid:21495716
Jenkins RW et al. Regulation of CC ligand 5/RANTES by acid sphingomyelinase and acid ceramidase. 2011 J. Biol. Chem. pmid:21335555
Pinschewer DD et al. Impact of sphingosine 1-phosphate modulation on immune outcomes. 2011 Neurology pmid:21339486
Mehling M et al. Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis. 2011 Neurology pmid:21339487
Hla T and Brinkmann V Sphingosine 1-phosphate (S1P): Physiology and the effects of S1P receptor modulation. 2011 Neurology pmid:21339489
Soliven B et al. The neurobiology of sphingosine 1-phosphate signaling and sphingosine 1-phosphate receptor modulators. 2011 Neurology pmid:21339490
Brecht K et al. Macrophages programmed by apoptotic cells promote angiogenesis via prostaglandin E2. 2011 FASEB J. pmid:21450910
Benamer N et al. Electrophysiological and functional effects of sphingosine-1-phosphate in mouse ventricular fibroblasts. 2011 Biochem. Biophys. Res. Commun. pmid:21420933
Ocaña-Morgner C et al. Sphingosine 1-phosphate-induced motility and endocytosis of dendritic cells is regulated by SWAP-70 through RhoA. 2011 J. Immunol. pmid:21421853
Kato K et al. Regulation by heat shock protein 27 of osteocalcin synthesis in osteoblasts. 2011 Endocrinology pmid:21427224
Delogu G et al. Lysophosphatidic acid enhances antimycobacterial response during in vivo primary Mycobacterium tuberculosis infection. 2011 Cell. Immunol. pmid:21703599
Sekine Y et al. HDL and sphingosine-1-phosphate activate stat3 in prostate cancer DU145 cells via ERK1/2 and S1P receptors, and promote cell migration and invasion. 2011 Prostate pmid:20979115
Noguchi K and Chun J Roles for lysophospholipid S1P receptors in multiple sclerosis. 2011 Crit. Rev. Biochem. Mol. Biol. pmid:20979571
Becker S et al. Follicular fluid high-density lipoprotein-associated sphingosine 1-phosphate (S1P) promotes human granulosa lutein cell migration via S1P receptor type 3 and small G-protein RAC1. 2011 Biol. Reprod. pmid:20980685
Barra V et al. Apoptotic cell-derived factors induce arginase II expression in murine macrophages by activating ERK5/CREB. 2011 Cell. Mol. Life Sci. pmid:20949368
Greenspon J et al. Sphingosine-1-phosphate regulates the expression of adherens junction protein E-cadherin and enhances intestinal epithelial cell barrier function. 2011 Dig. Dis. Sci. pmid:20936358
Wu LY et al. Metabolite modulation of HeLa cell response to ENOX2 inhibitors EGCG and phenoxodiol. 2011 Biochim. Biophys. Acta pmid:21571040
Jeffery DR et al. Fingolimod for the treatment of relapsing multiple sclerosis. 2011 Expert Rev Neurother pmid:21158700
Chi H Sphingosine-1-phosphate and immune regulation: trafficking and beyond. 2011 Trends Pharmacol. Sci. pmid:21159389
Jee BC et al. Dose-dependent effect of sphingosine-1-phosphate in mouse oocyte maturation medium on subsequent embryo development. 2011 Gynecol. Obstet. Invest. pmid:21160167
Kim YM et al. G(alpha)12/13 induction of CYR61 in association with arteriosclerotic intimal hyperplasia: effect of sphingosine-1-phosphate. 2011 Arterioscler. Thromb. Vasc. Biol. pmid:21212405
Kharel Y et al. A rapid assay for assessment of sphingosine kinase inhibitors and substrates. 2011 Anal. Biochem. pmid:21216217
Gaveglio VL et al. Metabolic pathways for the degradation of phosphatidic acid in isolated nuclei from cerebellar cells. 2011 Arch. Biochem. Biophys. pmid:21216221
Ter Braak M et al. Cis-4-methylsphingosine is a sphingosine-1-phosphate receptor modulator. 2011 Biochem. Pharmacol. pmid:21163254
Markiewicz M et al. Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells. 2011 Microcirculation pmid:21166920
Sassoli C et al. Effects of S1P on skeletal muscle repair/regeneration during eccentric contraction. 2011 J. Cell. Mol. Med. pmid:21199328
Jang S et al. Modulation of sphingosine 1-phosphate and tyrosine hydroxylase in the stress-induced anxiety. 2011 Neurochem. Res. pmid:21076868
Jongsma M et al. LPA is a chemorepellent for B16 melanoma cells: action through the cAMP-elevating LPA5 receptor. 2011 PLoS ONE pmid:22195035
Finney CA et al. S1P is associated with protection in human and experimental cerebral malaria. 2011 Mol. Med. pmid:21556483
Bradley ME et al. The in vitro metabolism of sphingosine-1-phosphate: identification; inhibition and pharmacological implications. 2011 Eur. J. Pharmacol. pmid:21970805
Lan T et al. Sphingosine kinase-1 pathway mediates high glucose-induced fibronectin expression in glomerular mesangial cells. 2011 Mol. Endocrinol. pmid:21998146
Kang H et al. Fluid shear stress and sphingosine 1-phosphate activate calpain to promote membrane type 1 matrix metalloproteinase (MT1-MMP) membrane translocation and endothelial invasion into three-dimensional collagen matrices. 2011 J. Biol. Chem. pmid:22002053
Gomez L et al. A novel role for mitochondrial sphingosine-1-phosphate produced by sphingosine kinase-2 in PTP-mediated cell survival during cardioprotection. 2011 Basic Res. Cardiol. pmid:22002221
Kartal M et al. Resveratrol triggers apoptosis through regulating ceramide metabolizing genes in human K562 chronic myeloid leukemia cells. 2011 Nutr Cancer pmid:21500096
Costello RW et al. Mechanism of sphingosine 1-phosphate- and lysophosphatidic acid-induced up-regulation of adhesion molecules and eosinophil chemoattractant in nerve cells. 2011 Int J Mol Sci pmid:21686182